Early study on cancer drug subasumstat halted after just 3 patients
NCT ID NCT05976334
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 33 times
Summary
This study looked at how the body absorbs, breaks down, and gets rid of a drug called subasumstat in people with advanced solid tumors that had no other treatment options. Only 3 adults took part before the study was stopped early. The goal was to measure the drug's path through the body, not to test if it works as a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Central Hospital of Northern Pest - Military Hospital
Budapest, 1062, Hungary
-
Pharmaceutical Research Associates Magyarorszag
Budapest, 1077, Hungary
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.